PATENT CLAIM ANALYSIS

Application Number: 15777009
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "190100"]

Abstract:
The present invention provides a multi-peptide composition with antibacterial activity comprising at least 3 peptides with the sequences as set forth in SEQ ID NO:1, 2 or 3 (or related sequences), respectively, in which the SEQ ID NO:1 sequence (or its related sequence) comprises at least two tryptophan residues. In particular the invention provides a new bacteriocin, Garvicin KS. The invention also provides compositions and host cells containing such antibacterial compositions. Uses of the antibacterial composition in treating bacterial infection and products treated with the antibacterial composition are also provided.

Claim (Index 14):
A nucleic acid molecule comprising:\n i) a nucleotide sequence encoding at least one of\n a) a peptide comprising the sequence as set forth in SEQ ID NO:1 (GarA) or a sequence with at least 90% sequence identity thereto; \n b) a peptide comprising the sequence as set forth in SEQ ID NO:2 (GarB) or a sequence with at least 90% sequence identity thereto; and \n c) a peptide comprising the sequence as set forth in SEQ ID NO:3 (GarC) or a sequence with at least 90% sequence identity thereto; \n wherein the sequence as set forth in SEQ ID NO:1 or said sequence with at least 90% sequence identity thereto comprises at least two tryptophan residues, wherein preferably a) is a peptide comprising or consisting of the sequence as set forth in SEQ ID NO:1 (GarA), b) is a peptide comprising or consisting of the sequence as set forth in SEQ ID NO:2 (GarB), and/or c) is a peptide comprising or consisting of the sequence as set forth in SEQ ID NO:3 (GarC); or ii) a nucleotide sequence comprising at least one of\n a) a nucleotide sequence as set forth in SEQ ID NO:14 (GarA) or a sequence with at least 90% sequence identity thereto; \n b) a nucleotide sequence as set forth in SEQ ID NO:15 (GarB) or a sequence with at least 90% sequence identity thereto; and \n c) a nucleotide sequence as set forth in SEQ ID NO:16 (GarC) or a sequence with at least 90% sequence identity thereto; \n wherein the sequence encoded by the sequence as set forth in SEQ ID NO:14 or said sequence with at least 90% sequence identity thereto comprises at least two tryptophan residues, wherein preferably a) is a nucleotide sequence comprising or consisting of the sequence as set forth in SEQ ID NO:14 (GarA), b) is a nucleotide sequence comprising or consisting of the sequence as set forth in SEQ ID NO:15 (GarB), and/or c) is a nucleotide sequence comprising or consisting of the sequence as set forth in SEQ ID NO:16 (GarC).

Metadata:
- Claim Count in Document: 18.0
- Percentile: 93.0
- Lexical Diversity: 1.67213
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10296723', '13516534', '14278423', '12745299', '11129337']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.697259865209299
- 35 USC 102 Novelty (BERT): 0.5091441540583118
- Combined Prediction Score: 0.6784482940942003
- Mean Citation Score: 259.020846
- Max Citation Score: 267.97522000000004
- Similarity Product: 199.17506133530264

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test